{
  "meta": {
    "title": "Nephritic_Syndrome",
    "url": "https://brainandscalpel.vercel.app/nephritic-syndrome-e94a768d.html",
    "scrapedAt": "2025-11-29T18:32:25.666Z"
  },
  "questions": [
    {
      "id": 14946,
      "choices": [
        {
          "id": 59744,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus nephritis </span></span></span></p>"
        },
        {
          "id": 59745,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangiocapillary glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59746,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diarrhea-associated hemolytic uremic syndrome </span></span></span></p>"
        },
        {
          "id": 59747,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-infections glomerulonephritis </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are associated with low complement levels except: </span></span></span></p>",
      "unique_key": "Q9265854",
      "question_audio": null,
      "question_video": null,
      "map_id": 32109,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Diarrhea associated hemolytic uremic syn&shy;drome </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diarrhea-associated Hemolytic Uremic Syndrome (HUS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically, in diarrhea-associated HUS, which is often caused by infection with <strong>Shiga toxin-producing E. coli,</strong> <strong>complement levels </strong>are <strong>not</strong> affected. This condition <strong>does not </strong>usually involve<strong> immune complex deposition or complement activation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lupus Nephritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In lupus nephritis, an <strong>autoimmune </strong>condition where the <strong>body&#39;s own immune system </strong>attacks the<strong> kidneys</strong>, <strong>low complement levels </strong>are common due to the <strong>consumption of complement </strong>in the formation of <strong>immune complexes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Mesangiocapillary Glomerulonephritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition, also known as <strong>membranoproliferative glomerulonephritis, </strong>involves the deposition of<strong> immune complexes </strong>in the <strong>mesangium and capillary walls of the kidneys</strong>, often leading to persistent<strong> low complement levels</strong>, particularly<strong> C3</strong>, due to the <strong>activation of the complement system</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Post-infectious Glomerulonephritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This usually occurs after infections such as <strong>streptococcal infection</strong>. While it can result in<strong> transient low complement levels </strong>due to<strong> immune complex deposition </strong>and <strong>complement activation</strong>, the levels usually return to <strong>normal within several weeks</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low complement levels </strong>are typically associated with conditions involving<strong> immune complex deposition </strong>and <strong>activation </strong>of the <strong>complement pathway</strong>, such as<strong> lupus nephritis, mesangiocapillary glomerulonephritis, and post-infectious glomerulonephritis.</strong> <strong>Diarrhea-associated hemolytic uremic syndrome</strong>, however,<strong> does not </strong>commonly involve <strong>complement system </strong>alterations, setting it apart from other causes of <strong>nephritic syndrome with low complement levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephritic syndrome associated with low C3 </span></span></strong></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture4_4LkejF5.jpg\" style=\"height:261px; width:1000px\" /></span></span></strong></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref:&nbsp; 10<sup>th</sup>/ 938) </span></em></strong></span></span></p>",
      "correct_choice_id": 59746,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14667,
      "choices": [
        {
          "id": 58629,
          "text": "<p><span style=\"font-size:12pt;\">Polyarteritis nodosa</span></p>"
        },
        {
          "id": 58630,
          "text": "<p><span style=\"font-size:12pt;\">Systemic hypertension</span></p>"
        },
        {
          "id": 58631,
          "text": "<p><span style=\"font-size:12pt;\">Malignant hypertension</span></p>"
        },
        {
          "id": 58632,
          "text": "<p><span style=\"font-size:12pt;\">Wegeners disease</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 65-year-old woman complains of increased fatigue since last 2 years. Her serum creatinine and blood urea nitrogen are raised. USG shows both kidneys symmetrically reduced in size. Kidney biopsy done shows the following finding. What is the likely diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3qbCYsK.png\" width=\"557\" height=\"372\"></p>",
      "unique_key": "Q8190525",
      "question_audio": null,
      "question_video": null,
      "map_id": 32098,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Systemic hypertension</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This is <strong>hyaline arteriosclerosis</strong> of vessel wall seen in <strong>benign hypertension</strong> wherein the <strong>kidneys are symmetrically contracted</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Similar changes can also be seen in <strong>diabetes mellitus.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>systemic hypertension, </strong>especially <strong>long-standing and poorly controlled cases</strong>, <strong>hyaline arteriosclerosis of the vessel wall </strong>can occur, leading to symmetrically<strong> reduced kidney size</strong>. This finding is consistent with the<strong> patient’s presentation and biopsy </strong>results.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Polyarteritis nodosa </strong>typically presents with <strong>vasculitis and fibrinoid necrosis </strong>on kidney biopsy. It is characterized by <strong>segmental necrotizing inflammation of medium-sized arteries, </strong>which would be evident on histological examination.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Malignant hypertension </strong>typically presents with <strong>\"flea-bitten\" kidneys </strong>on imaging and demonstrates<strong> fibrinoid necrosis </strong>on kidney biopsy. This <strong>patient's presentation, including symmetrically reduced kidney size and the absence of fibrinoid necrosis</strong>, is not consistent with malignant hypertension.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Wegener's granulomatosis </strong>is characterized by<strong> granulomatous </strong>inflammation of the vessel wall. However, the histological findings described in the<strong> patient's kidney biopsy do not align with this diagnosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Symmetrically reduced kidney size </strong>with<strong> hyaline arteriosclerosis </strong>of the vessel wall is indicative of <strong>systemic hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Onion-skinning of blood vessels in kidney is seen in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Malignant hypertension</span></li><li><span style=\"font-size:16px;\">Chronic transplant rejection</span></li><li><span style=\"font-size:16px;\">Thrombotic microangiopathies (e.g., HUS, TTP)</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ p492)</strong></span></p>",
      "correct_choice_id": 58630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14947,
      "choices": [
        {
          "id": 59748,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post streptococcal glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59749,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranoproliferative glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59750,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodpasture&rsquo;s disease </span></span></span></p>"
        },
        {
          "id": 59751,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic lupus erythematosus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are associated with low C3 level except:<em> </em></span></span></span></p>",
      "unique_key": "Q6971915",
      "question_audio": null,
      "question_video": null,
      "map_id": 32110,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Goodpasture&rsquo;s disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodpasture&rsquo;s disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an <strong>autoimmune disease</strong> where <strong>antibodies target the basement membrane in the lungs and kidneys</strong>. Typically, it is <strong>not associated with low serum C3 levels</strong> because the pathophysiology <strong>does not </strong>involve the <strong>classical complement</strong> <strong>pathway activation</strong> that consumes C3.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Goodpasture&#39;s disease </strong>is<strong> not typically </strong>associated with <strong>low C3 levels</strong>. It is <strong>an autoimmune disease </strong>characterized by the presence of <strong>antibodies directed against the glomerular basement membrane and alveolar basement membrane </strong>in the lungs. This condition primarily involves the<strong> lungs and kidneys</strong>. While it can cause <strong>glomerulonephritis, </strong>it <strong>does not </strong>usually result in<strong> low C3 levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Post-streptococcal glomerulonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition often follows a <strong>streptococcal infection </strong>and is characterized by an <strong>acute immune response</strong>. It leads to <strong>decreased </strong>levels of <strong>complement C3 </strong>due to the <strong>activation </strong>of the<strong> complement system</strong> by <strong>immune complexes</strong> deposited in the glomeruli.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Membranoproliferative glomerulonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>chronic </strong>condition involves <strong>immune complexes and complement deposition </strong>in the kidneys, resulting in persistent<strong> low serum C3 levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Systemic lupus erythematosus (SLE):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> SLE is a <strong>systemic autoimmune disease </strong>that can cause a wide array of clinical manifestations, including <strong>lupus nephritis</strong>. <strong>Immune complexes </strong>formed in <strong>SLE activate </strong>the <strong>complement system</strong>, leading to reduced <strong>serum C3 levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-streptococcal glomerulonephritis and membranoproliferative glomerulonephritis </strong>commonly cause <strong>low serum C3 levels </strong>due to <strong>complement activation and consumption</strong>. In <strong>contrast</strong>,<strong> Goodpasture&rsquo;s disease does not </strong>typically result in <strong>low C3 levels </strong>as its pathogenesis <strong>does not </strong>involve immune complexes that <strong>activate complement. Systemic lupus erythematosus </strong>often presents with <strong>low C3 due to immune complex-mediated complement activation</strong>. </span></span></span></p>",
      "correct_choice_id": 59750,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14932,
      "choices": [
        {
          "id": 59688,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hyaline degeneration</span></p>"
        },
        {
          "id": 59689,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hyperplastic arteriosclerosis</span></p>"
        },
        {
          "id": 59690,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Glomerulosclerosis</span></p>"
        },
        {
          "id": 59691,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Fibrillary glomerulonephritis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In a specimen of kidney, fibrinoid necrosis is seen and onion peel appearance is also present. Most probable pathology is:</span></p>",
      "unique_key": "Q1469193",
      "question_audio": null,
      "question_video": null,
      "map_id": 32099,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Hyperplastic arteriosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture1_9ImuYlJ.jpg\" alt=\"\" width=\"1000\" height=\"273\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Hyaline degeneration </strong>refers to the accumulation of<strong> homogenous, eosinophilic material (hyaline) </strong>in tissues. It is not typically associated with fibrinoid necrosis or an onion peel appearance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Glomerulosclerosis </strong>involves <strong>scarring and hardening of the glomeruli </strong>in the kidneys. It may not typically present with fibrinoid necrosis and an onion peel appearance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Fibrillary glomerulonephritis </strong>is a renal disease characterized by the<strong> deposition of fibrillary immune complexes </strong>in the <strong>glomeruli</strong>. Fibrinoid necrosis and an onion peel appearance are not typically associated with fibrillary glomerulonephritis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective</u></strong><u>:</u></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Hyperplastic arteriosclerosis </strong>is characterized by <strong>\"onion skin\" or \"string of beads</strong>\" appearance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 935)</strong></i></span></p>",
      "correct_choice_id": 59689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14942,
      "choices": [
        {
          "id": 59728,
          "text": "<p><span style=\"font-size:12pt;\">Rapidly progressive glomerulonephritis</span></p>"
        },
        {
          "id": 59729,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Alport syndrome</span></p>"
        },
        {
          "id": 59730,
          "text": "<p><span style=\"font-size:12pt;\">Goodpasture’s syndrome</span></p>"
        },
        {
          "id": 59731,
          "text": "<p><span style=\"font-size:12pt;\">Henoch-Schönlein purpura</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 45-year-old man with a history of autoimmune disorders presents with fatigue, edema, and cola-colored urine. Laboratory studies reveal elevated serum creatinine, proteinuria, and hematuria. Urinalysis shows dysmorphic red blood cells and red cell casts. Renal biopsy reveals cellular crescents and fibrinoid necrosis in glomeruli. Which of these does not cause crescentic glomerulone­phritis?</span></p>",
      "unique_key": "Q8571310",
      "question_audio": null,
      "question_video": null,
      "map_id": 32105,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Alport syndrome</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport syndrome </strong>is a <strong>genetic disorder </strong>caused by mutations in genes encoding <strong>type IV collagen</strong>. It primarily affects the<strong> kidneys, ears, and eyes. </strong>However, <strong>crescentic glomerulonephritis </strong>is <strong>not </strong>a characteristic feature of <strong>Alport syndrome</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Crescentic glomerulonephritis </strong>is a <strong>histopathological </strong>pattern of<strong> glomerular injury </strong>characterized by the presence of<strong> crescents in Bowman's space</strong>. Various diseases and conditions can cause crescentic glomerulonephritis. Let's look at the provided options:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>Rapidly progressive glomerulonephritis (RPGN) </strong>is a term used to describe a<strong> clinical presentation </strong>rather than a <strong>specific disease. </strong>Conditions like <strong>ANCA-associated vasculitis, anti-GBM (Goodpasture's syndrome), and immune complex-mediated glomerulonephritis </strong>can present as <strong>RPGN with crescents.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Goodpasture's syndrome </strong>is an <strong>autoimmune disease </strong>characterized by the presence of <strong>anti-GBM antibodies</strong>. It can lead to <strong>rapidly progressive glomerulonephritis </strong>with <strong>crescent formation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Henoch-Schönlein purpura (HSP) </strong>is a <strong>systemic vasculitis </strong>that affects <strong>small vessels</strong>, including glomerular capillaries. Crescentic glomerulonephritis can occur in some cases of HSP.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport syndrome </strong>does<strong> not </strong>cause <strong>crescentic glomerulone­phritis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ p922)</strong></i></span></p>",
      "correct_choice_id": 59729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14937,
      "choices": [
        {
          "id": 59708,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nodular glomerulosclerosis </span></span></span></p>"
        },
        {
          "id": 59709,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal necrotizing glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59710,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granulomas in the vascular wall </span></span></span></p>"
        },
        {
          "id": 59711,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granuloma of parenchyma of kidney </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathological feature in Wegener&rsquo;s granulomatosis on renal biopsy is?</span></span></span></p>",
      "unique_key": "Q1047280",
      "question_audio": null,
      "question_video": null,
      "map_id": 32100,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Focal necrotizing glomerulonephritis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Focal necrotizing glomerulonephritis </strong>is a <strong>hallmark of GPA</strong>. This reflects <strong>active glomerular inflammation and necrosis </strong>without significant<strong> immune deposits, </strong>characteristic of <strong>pauci-immune glomerulonephritis</strong>.</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lsquo;The<strong> renal lesions </strong>range from a mild/ early disease, where <strong>glomeruli show acute focal necrosis with thrombosis </strong>of <strong>isolated glomerular capillary loops </strong>(focal and segmental necrotizing glomerulonephritis) whereas <strong>advanced glomerular lesions </strong>are characterized by <strong>diffuse necrosis and parietal cell proliferation </strong>to form <strong>crescents </strong>(crescentic glomerulonephritis)&rsquo;&hellip;&hellip;Robbins&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct quote from Harrison&hellip;&hellip;.. <strong>&ldquo;Necrotizing vas&shy;culitis of small arteries and veins </strong><em>with<strong> granuloma for&shy;mation </strong></em>is seen in <strong>pulmonary tissue </strong>whereas<strong> granu&shy;loma formation </strong>is <strong><em>rarely seen </em>on <em>renal biopsy&rdquo;. </em></strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Nodular glomerulosclerosis </strong>is<strong> not </strong>a typical feature of<strong> GPA.</strong> This finding is <strong>more commonly </strong>associated with <strong>diabetic nephropathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>While granulomas </strong>are a defining feature of <strong>GPA, </strong>they are <strong>more </strong>commonly seen in<strong> pulmonary tissue </strong>and <strong>not </strong>as frequently observed within the <strong>vascular walls in the kidney </strong>on biopsy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to option C,<strong> granulomas can be </strong>found in <strong>GPA </strong>but are <strong>more </strong>commonly<strong> identified in the respiratory tract </strong>than in the <strong>parenchyma of the kidney</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wegener&rsquo;s granulomatosis</strong>, or <strong>Granulomatosis with Polyangiitis</strong>, typically presents on <strong>renal biopsy </strong>with <strong>focal necrotizing glomerulonephritis</strong>, often with <strong>crescent formation</strong>, reflecting its classification as a form of <strong>pauci-immune glomerulonephritis. Granulomas</strong>, while a <strong>central feature in the lungs</strong>, are<strong> rarely seen in renal biopsies </strong>for this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 910) </span></span></em></strong> </em></span></span></p>",
      "correct_choice_id": 59709,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14938,
      "choices": [
        {
          "id": 59712,
          "text": "<p><span style=\"font-size:12pt;\">Fibrin caps and capsular drops</span></p>"
        },
        {
          "id": 59713,
          "text": "<p><span style=\"font-size:12pt;\">Kimmelstein-Wilson lesion</span></p>"
        },
        {
          "id": 59714,
          "text": "<p><span style=\"font-size:12pt;\">Basement membrane thickening</span></p>"
        },
        {
          "id": 59715,
          "text": "<p><span style=\"font-size:12pt;\">Focal glomerular sclerosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pathological changes of diabetic nephropathy are all except:</span></p>",
      "unique_key": "Q7871845",
      "question_audio": null,
      "question_video": null,
      "map_id": 32101,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Focal glomerular sclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Diabetic nephropathy </strong>is characterized by <strong>several pathological changes</strong>, and the options provided are associated with these changes:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Fibrin caps and capsular drops:</strong> These are characteristic of <strong>diabetic nephropathy</strong>. <strong>Fibrin caps</strong> are formed from the <strong>extravasation of plasma proteins </strong>into <strong>Bowman's space,</strong> and <strong>capsular drops are hyaline droplets</strong> in the<strong> renal tubules.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Kimmelstein-Wilson lesion:</strong> This refers to nodular <strong>glomerulosclerosis, </strong>which is a classic finding in <strong>diabetic nephropathy.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Basement membrane thickening:</strong> Thickening of the<strong> glomerular basement membrane </strong>is a <strong>hallmark of diabetic nephropathy</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Focal glomerular sclerosis (FSGS) </strong>is <strong>not a typical </strong>finding in <strong>diabetic nephropathy</strong>. It is a <strong>separate entity </strong>that can be associated with other conditions.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The characteristic pathological features of <strong>diabetic nephropathy</strong>, include <strong>Kimmelstiel-Wilson lesions (nodular glomerulosclerosis), thickening of the glomerular basement membrane</strong>, and <strong>the presence of fibrin caps and capsular drops</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 923)&nbsp;</strong></i></span></p>",
      "correct_choice_id": 59715,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14939,
      "choices": [
        {
          "id": 59716,
          "text": "<p><span style=\"font-size:12pt;\">Loss of antithrombin III (AT III)</span></p>"
        },
        {
          "id": 59717,
          "text": "<p><span style=\"font-size:12pt;\">Decreased fibrinogen</span></p>"
        },
        {
          "id": 59718,
          "text": "<p><span style=\"font-size:12pt;\">Decreased metabolism of vitamin K</span></p>"
        },
        {
          "id": 59719,
          "text": "<p><span style=\"font-size:12pt;\">Increase in Protein C</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">What is the cause of hypercoagulation in nephrotic syndrome?</span></p>",
      "unique_key": "Q6443227",
      "question_audio": null,
      "question_video": null,
      "map_id": 32102,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Loss of antithrombin III (AT III)</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Loss of antithrombin III (AT III):</strong> <strong>In nephrotic syndrome</strong>, there is<strong> increased urinary loss of proteins</strong> including <strong>antithrombin III</strong>, which is a <strong>natural anticoagulant</strong>. <strong>AT III </strong>inhibits <strong>thrombin and factor Xa </strong>in the<strong> coagulation cascade</strong>. Its <strong>loss </strong>contributes significantly to the <strong>hypercoagulable state in nephrotic syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Thrombotic and thromboembolic </strong>complications are com­mon in <strong>nephrotic syndrome due to loss of anticoagulant factor (e.g. antithrombin III, protein C and S) </strong>combined with<strong> increased platelet activation</strong>. <strong>Renal vein thrombo­sis </strong>is most often a <strong>consequence </strong>of this<strong> hypercoagulative state</strong>. There is also <strong>increased synthesis of fibrinogen </strong>in the liver.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> hypercoagulable </strong>state in <strong>nephrotic syndrome </strong>is <strong>multifactorial</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Decreased fibrinogen:</strong> This statement is<strong> incorrect </strong>with respect to<strong> nephrotic syndrome</strong>. Actually, there is an<strong> increased synthesis of fibrinogen in the liver</strong>, <strong>not decreased</strong>. <strong>Fibrinogen </strong>is an <strong>acute phase reactant</strong>, and its levels are <strong>increased in nephrotic syndrome, </strong>which contributes to a<strong> hypercoagulable state</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Decreased metabolism of vitamin K:</strong> This statement is<strong> not </strong>directly related to the <strong>hypercoagulable </strong>state in <strong>nephrotic syndrome</strong>. <strong>Vitamin K </strong>is essential for the <strong>synthesis </strong>of certain clotting factors <strong>(II, VII, IX, X), </strong>and its<strong> metabolism </strong>can be <strong>affected </strong>in <strong>liver disease</strong>, <strong>not </strong>typically in<strong> nephrotic syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Increase in Protein C:</strong> This is <strong>not correct</strong>. While <strong>Protein C is an anticoagulant</strong>, similar to<strong> antithrombin III</strong>, in <strong>nephrotic syndrome</strong>, there can be a<strong> loss of Protein C through the urine, </strong>which would contribute to a<strong> hypercoagulable state </strong>rather than <strong>mitigating it</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Nephrotic syndrome </strong>is associated with a <strong>hypercoagulable state </strong>primarily due to <strong>urinary losses of anticoagulant proteins </strong>such as <strong>antithrombin III</strong>, often leading to thrombotic complications like <strong>renal vein thrombosis</strong>. The <strong>liver's increased synthesis of procoagulant </strong>factors such as<strong> fibrinogen also contributes </strong>to this state.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10h/ 911)</strong></i></span></p>",
      "correct_choice_id": 59716,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14940,
      "choices": [
        {
          "id": 59720,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrin</span></p>"
        },
        {
          "id": 59721,
          "text": "<p><span style=\"font-size:12pt;\">Podocin</span></p>"
        },
        {
          "id": 59722,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Alpha actinin</span></p>"
        },
        {
          "id": 59723,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">CD2 activated protein</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Finnish type of nephrotic syndrome is associated with:</span></p>",
      "unique_key": "Q9890443",
      "question_audio": null,
      "question_video": null,
      "map_id": 32103,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Nephrin</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Nephrin:</strong> Nephrin is a<strong> key structural and signaling protein </strong>that is part of the<strong> slit diaphragm of glomerular podocytes </strong>in the kidney. <strong>Mutations </strong>in the gene encoding nephrin<strong> (NPHS1) </strong>are responsible for <strong>Finnish-type congenital nephrotic syndrome</strong>. This condition is characterized by <strong>massive proteinuria </strong>starting in<strong> utero or shortly after birth </strong>and often <strong>leads to renal failure</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Lipoid nephrosis </strong>or<strong> nephrotic syndrome </strong>is also called as <strong>minimal change disease</strong>.<strong> Congenital nephrotic syndrome </strong>occurs as a result of<strong> mutation </strong>in the <strong>nephrin </strong>gene. (<strong>Finnish type of nephrotic syndrome</strong>)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Podocin:</strong> Podocin is another <strong>protein </strong>that is important in the structure of the <strong>slit diaphragm of podocytes</strong>. <strong>Mutations </strong>in the gene encoding podocin<strong> (NPHS2) </strong>cause <strong>autosomal recessive steroid-resistant nephrotic syndrome</strong>, which is <strong>different from </strong>the <strong>Finnish type </strong>but also results in significant <strong>proteinuria.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Alpha-actinin:</strong> Alpha-actinin is a <strong>cytoskeletal actin-binding protein </strong>that is involved in maintaining the structure of the <strong>podocyte foot processes </strong>and the <strong>slit diaphragm</strong>. Mutations here can also cause<strong> nephrotic syndrome</strong>, but they are <strong>not </strong>associated with the <strong>Finnish type of nephrotic syndrome</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: CD2-associated protein (CD2AP):</strong> CD2AP is a molecule involved in the <strong>structure and function of the slit diaphragm </strong>and the <strong>actin cytoskeleton in podocytes</strong>. <strong>Mutations in CD2AP </strong>can lead to <strong>nephrotic syndrome</strong>, <strong>highlighting </strong>its role in<strong> maintaining </strong>the <strong>glomerular filtration barrier.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Finnish type nephrotic syndrome </strong>is caused by<strong> mutations </strong>in the<strong> nephrin gene.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QY44t94.png\" width=\"1428\" height=\"394\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 915)</strong></span></p>",
      "correct_choice_id": 59720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14941,
      "choices": [
        {
          "id": 59724,
          "text": "<p><span style=\"font-size:12pt;\">Granulomatosis with polyangiitis</span></p>"
        },
        {
          "id": 59725,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">SLE</span></p>"
        },
        {
          "id": 59726,
          "text": "<p><span style=\"font-size:12pt;\">Henoch Schonlein Purpura</span></p>"
        },
        {
          "id": 59727,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Polyarteritis nodosa</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pauci-immune crescentic glomerulonephritis is associated with:</span></p>",
      "unique_key": "Q3539335",
      "question_audio": null,
      "question_video": null,
      "map_id": 32104,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. A)&nbsp;Granulomatosis with polyangiitis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Granulomatosis with polyangiitis (GPA):</strong> GPA is closely associated with pauci-immune crescentic glomerulonephritis, which is a type of inflammation of the kidney that does not involve significant deposits of immune complexes or antibodies. ANCA, particularly c-ANCA with PR3 specificity, is commonly found in patients with GPA.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Pauci-immune crescentic glomerulonephritis is most commonly associated with ANCA (antineutrophil cytoplasmic antibody)-associated vasculitides. Granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis, is one of the ANCA-associated vasculitides and is strongly associated with pauci-immune crescentic glomerulonephritis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The association of pauci-immune crescentic glomerulonephritis:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Systemic lupus erythematosus (SLE):</strong> SLE can affect the kidneys, leading to lupus nephritis, which often involves the deposition of immune complexes. Therefore, it is not typically classified as pauci-immune.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C: Henoch-Schonlein purpura (HSP):</strong> HSP is characterized by the deposition of IgA immune complexes, particularly affecting the small vessels, and it can lead to a type of crescentic glomerulonephritis but it is not pauci-immune.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D: Polyarteritis nodosa (PAN):</strong> PAN is a systemic necrotizing vasculitis that can affect medium-sized arteries and may cause renal damage. However, it is not primarily associated with pauci-immune crescentic glomerulonephritis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Pauci-immune crescentic glomerulonephritis is a form of rapidly progressing glomerulonephritis strongly associated with ANCA-associated vasculitides, particularly granulomatosis with polyangiitis. It is characterized by minimal or no immune complex deposition and can be differentiated from other forms of crescentic glomerulonephritis by the lack of significant immune deposits.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Type I RPGN = <strong>anti-GBM disease</strong> (Goodpasture’s).&nbsp;</span></li><li><span style=\"font-size:16px;\">Type II RPGN = <strong>immune complex-mediated</strong> (SLE, IgA nephropathy, post-infectious)</span></li><li><span style=\"font-size:16px;\">Type III RPGN = <strong>pauci-immune</strong> (ANCA-associated vasculitis)</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 910)</strong></span></p>",
      "correct_choice_id": 59724,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14943,
      "choices": [
        {
          "id": 59732,
          "text": "<p><span style=\"font-size:12pt;\">Membranous glomerulonephritis</span></p>"
        },
        {
          "id": 59733,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mesangiocapillary glomerulonephritis</span></p>"
        },
        {
          "id": 59734,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Diabetic glomerulosclerosis</span></p>"
        },
        {
          "id": 59735,
          "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">All are non-proliferative glomerulonephritis, except:</span></p>",
      "unique_key": "Q8682852",
      "question_audio": null,
      "question_video": null,
      "map_id": 32106,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Mesangiocapillary glomerulonephritis &nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mesangiocapillary glomerulonephritis:</strong> This condition, also known as<strong> type I membranoproliferative glomerulonephritis</strong>, is indeed a <strong>proliferative </strong>type. It's characterized by <strong>hypercellularity </strong>involving both <strong>mesangial cells and capillary loops</strong>, along with changes in the <strong>basement membrane and mesangial matrix.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Glomerular lesions </strong>with <strong>increased cells </strong>in the <strong>tufts</strong> are often known as <strong>proliferative glomerulonephritis</strong>. The following are the conditions with proliferative glomerulonephritis</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture3_7Tma1fD.jpg\" alt=\"\" width=\"1000\" height=\"183\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Membranous glomerulonephritis:</strong> This is a type of<strong> non-proliferative glomerulonephritis </strong>characterized by the <strong>thickening </strong>of the <strong>glomerular basement membrane </strong>without an increase in the number of cells<strong> (non-proliferative). </strong>It is often associated with the presence of <strong>immune complexes along the basement membrane.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Diabetic glomerulosclerosis:</strong> This refers to<strong> changes in the kidneys </strong>associated with <strong>diabetes mellitus </strong>and is characterized by <strong>thickening of the basement membrane and mesangial expansion</strong>. It <strong>does not </strong>involve an <strong>increase </strong>in the <strong>number of glomerular cells </strong>and is therefore considered <strong>non-proliferative</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Amyloidosis:</strong> Amyloidosis in the<strong> kidney </strong>leads to the deposition of <strong>amyloid proteins </strong>in the <strong>glomerulus. </strong>It is also<strong> non-proliferative</strong>, as it does not involve an increase in glomerular cell number.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Proliferative glomerulonephritis </strong>is defined by an<strong> increase in cellular elements </strong>within the<strong> glomerular structure</strong>, which is evident in <strong>mesangiocapillary glomerulonephritis</strong></span></p></li><li><span style=\"font-size:12pt;\">Non-proliferative: membranous glomerulonephritis, diabetic glomerulosclerosis, and amyloidosis.</span></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Anderson 10<sup>th</sup> /917)</strong></span></p>",
      "correct_choice_id": 59733,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14944,
      "choices": [
        {
          "id": 59736,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Thrombotic microangiopathy</span></p>"
        },
        {
          "id": 59737,
          "text": "<p><span style=\"font-size:12pt;\">Proliferative glomerulonephritis</span></p>"
        },
        {
          "id": 59738,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Focal segmental glomerulosclerosis</span></p>"
        },
        {
          "id": 59739,
          "text": "<p><span style=\"font-size:12pt;\">Minimal change disease</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Kidney biopsy from a child with hemolytic uremic syndrome characteristically most likely presents features of:</span></p>",
      "unique_key": "Q9336541",
      "question_audio": null,
      "question_video": null,
      "map_id": 32107,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Thrombotic microangiopathy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Thrombotic Microangiopathy:</strong> This is the correct diagnosis for<strong> hemolytic uremic syndrome (HUS). </strong>It involves the presence of <strong>microthrombi in the small blood vessels </strong>of the kidney, which leads to<strong> mechanical damage to red blood cells </strong>as they <strong>pass </strong>through the <strong>partially occluded vessels</strong>, causing a characteristic type of <strong>anemia </strong>known as <strong>microangiopathic hemolytic anemia</strong>, along with <strong>thrombocytopenia </strong>due to<strong> platelet consumption and acute kidney injury.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Proliferative Glomerulonephritis:</strong> This involves an <strong>increase </strong>in the<strong> number of cells </strong>in the<strong> glomeruli</strong>, typically due to an <strong>immune or inflammatory response</strong>. It is <strong>not </strong>typically associated with <strong>HUS</strong>, which is characterized by<strong> microangiopathic changes </strong>rather than cellular proliferation in the glomeruli.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Focal Segmental Glomerulosclerosis (FSGS):</strong> This condition is characterized by <strong>segments of the glomeruli </strong>showing <strong>scarring</strong>, which can lead to<strong> proteinuria and nephrotic syndrome</strong>. While<strong> FSGS </strong>can result in <strong>renal failure</strong>, it is<strong> not </strong>a characteristic feature of <strong>HUS.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Minimal Change Disease:</strong> This is a kidney disorder that causes<strong> nephrotic syndrome</strong>, especially in<strong> children</strong>, and is characterized by <strong>minimal changes </strong>detectable by <strong>light microscopy</strong>. It's associated with<strong> good prognosis </strong>and typically <strong>responds </strong>well to <strong>steroids.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>patients </strong>presenting with the clinical triad of<strong> microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury</strong>, a kidney biopsy is likely to reveal <strong>thrombotic microangiopathy, </strong>a pathology characteristic of<strong> hemolytic uremic syndrome</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 939)</strong></i></span></p>",
      "correct_choice_id": 59736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14945,
      "choices": [
        {
          "id": 59740,
          "text": "<p><span style=\"font-size:12pt;\">Post streptococcal glomerulonephritis</span></p>"
        },
        {
          "id": 59741,
          "text": "<p><span style=\"font-size:12pt;\">Membranoproliferative glomerulonephritis type II</span></p>"
        },
        {
          "id": 59742,
          "text": "<p><span style=\"font-size:12pt;\">Lupus nephritis</span></p>"
        },
        {
          "id": 59743,
          "text": "<p><span style=\"font-size:12pt;\">Glomerulonephritis related to bacterial endocarditis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Serum C3 is persistently low in the following except:</span></p>",
      "unique_key": "Q2609140",
      "question_audio": null,
      "question_video": null,
      "map_id": 32108,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Post streptococcal glomerulonephritis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Post Streptococcal Glomerulonephritis:</strong> After an infection with certain <strong>strains of Streptococcus, serum C3 </strong>levels typically <strong>decrease </strong>due to activation of the<strong> complement system</strong>. However, this<strong> decrease is transient and serum C3 levels </strong>usually <strong>normalize </strong>within <strong>6 to 8 weeks</strong>. Therefore, persistently<strong> low serum C3 levels </strong>are<strong> not </strong>characteristic of <strong>poststreptococcal glomerulonephritis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The terms of serum C3 levels in different renal pathologies:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Membranoproliferative Glomerulonephritis type II:</strong> This condition can cause persistently <strong>low serum C3 levels</strong>, often related to the presence of<strong> C3 nephritic factors </strong>that continuously activate the <strong>alternative complement pathway, </strong>leading to <strong>complement consumption</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Lupus Nephritis:</strong> In <strong>systemic lupus erythematosus (SLE), </strong>including <strong>lupus nephritis</strong>, both <strong>classical and alternative complement pathways </strong>can be activated by <strong>immune complexes</strong>, leading to persistent<strong> depression of complement components</strong>, including<strong> C3</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Glomerulonephritis Related to Bacterial Endocarditis:</strong> This condition is also associated with<strong> immune complex deposition </strong>that can <strong>consume complement</strong>. Persistent<strong> low serum C3 </strong>levels may be observed, depending on the<strong> chronicity and activity of the infection</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Serum complement levels</strong>, specifically<strong> C3</strong>, can be a valuable clinical marker in the <strong>diagnosis and monitoring of glomerular diseases. Poststreptococcal glomerulonephritis </strong>typically presents with<strong> transient low serum C3 levels, </strong>which recover<strong> within a few weeks</strong>, unlike other conditions such as<strong> membranoproliferative glomerulonephritis, lupus nephritis, and glomerulonephritis </strong>related to <strong>bacterial endocarditis, </strong>which may show <strong>persistent low levels </strong>indicative of ongoing<strong> complement activation and consumption.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">C3 Levels in Different Types of GN:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8iXZzjK.png\" width=\"1301\" height=\"586\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> 906)</strong></span></p>",
      "correct_choice_id": 59740,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14948,
      "choices": [
        {
          "id": 59752,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathological changes are proliferative and usu&shy;ally confined to mesangial cells; usually focal and segmental</span></span></span></p>"
        },
        {
          "id": 59753,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hematuria may be gross or microscopic </span></span></span></p>"
        },
        {
          "id": 59754,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">On immunofluorescence deposits contain with IgA and IgG </span></span></span></p>"
        },
        {
          "id": 59755,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absence of associated proteinuria is pathognomic </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man presents to the clinic with recurrent episodes of gross hematuria following upper respiratory tract infections. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not true about Berger&rsquo;s disease?<em> </em></span></span></span></p>",
      "unique_key": "Q9847886",
      "question_audio": null,
      "question_video": null,
      "map_id": 32111,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Absence of associated proteinuria is pathogno&shy;mic </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>absence of proteinuria </strong>is<strong> not </strong>pathognomonic for <strong>Berger&rsquo;s disease</strong>; on the contrary, <strong>proteinuria </strong>can be <strong>present and varies in severity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Berger&#39;s disease</strong>, also known as <strong>IgA nephropathy</strong>, is characterized by the deposition of<strong> IgA immune complexes </strong>in the<strong> glomerular mesangium</strong>. While it is <strong>true </strong>that <strong>Berger&#39;s disease </strong>often presents<strong> with hematuria </strong>(either gross or microscopic), the <strong>absence of associated proteinuria is not pathognomonic. </strong>In fact,<strong> proteinuria </strong>can occur in <strong>some cases of IgA nephropathy, </strong>and the severity can vary. <strong>Proteinuria </strong>is<strong> not </strong>consistently <strong>absent in Berger&#39;s disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Berger&rsquo;s disease, or IgA nephropathy, </strong>indeed shows<strong> mesangial proliferation. </strong>This is often a<strong> focal and segmental process </strong>within the <strong>glomeruli </strong>and is characteristic of the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Hematuria</strong>, which may be<strong> gross (visible) or microscopic</strong>, is a common finding in Berger&#39;s disease and can be one of the initial signs of the condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Immunofluorescence </strong>typically shows <strong>mesangial deposits primarily composed of IgA</strong>, and sometimes <strong>IgG and C3 </strong>may be present. The predominance o<strong>f IgA deposition </strong>is a defining feature of <strong>IgA nephropathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> characteristic </strong>pathological feature of <strong>Berger&rsquo;s disease </strong>is the deposition of<strong> IgA immune complexes </strong>in the<strong> glomerular mesangium</strong>. <strong>IgA nephropathy </strong>can present with a<strong> range of symptoms </strong>from <strong>isolated hematuria to nephrotic syndrome </strong>with significant <strong>proteinuria. </strong>A <strong>lack of proteinuria </strong>is<strong> not diagnostic of the disease. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> /920)</span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><em><span style=\"font-size:12.0pt\"><span style=\"color:black\"> </span></span></em></span></span></p>",
      "correct_choice_id": 59755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14950,
      "choices": [
        {
          "id": 59760,
          "text": "<p><span style=\"font-size:12pt;\">Glomerular granuloma</span></p>"
        },
        {
          "id": 59761,
          "text": "<p><span style=\"font-size:12pt;\">Interstitial granuloma</span></p>"
        },
        {
          "id": 59762,
          "text": "<p><span style=\"font-size:12pt;\">Crescentic glomerulonephritis</span></p>"
        },
        {
          "id": 59763,
          "text": "<p><span style=\"font-size:12.0pt;\">Glomerulosclerosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 40-year-old man presents with a 3-month history of recurrent sinusitis, cough, and hemoptysis. Physical examination reveals saddle-nose deformity and purpuric skin lesions on the lower extremities. Laboratory studies show elevated inflammatory markers and positive anti-neutrophil cytoplasmic antibodies (c-ANCA). In Wegener’s granulomatosis, kidney has which of the following lesions?</span></p>",
      "unique_key": "Q1929777",
      "question_audio": null,
      "question_video": null,
      "map_id": 32113,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Crescentic glomerulonephritis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Wegener's granulomatosis </strong>often presents with <strong>necrotizing granulomatous inflammation </strong>in the <strong>respiratory tract and necrotizing vasculitis </strong>affecting<strong> small- to medium-sized vessels. </strong>In the kidney, this <strong>vasculitis </strong>can lead to<strong> crescentic glomerulonephritis, </strong>which is a characteristic renal manifestation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Options A:&nbsp;</strong>and <strong>Option C:</strong> <strong>glomerular and interstitial granuloma </strong>is <strong>not </strong>a typical finding in <strong>Wegener's granulomatosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Wegener's granulomatosis </strong>primarily involves<strong> small vessels </strong>and may cause <strong>granulomatous inflammation </strong>in the <strong>interstitial tissues</strong>, but<strong> glomerular and interstitial granulomas </strong>are<strong> not a defining feature</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Glomerulosclerosis </strong>is<strong> not </strong>a typical lesion seen in<strong> Wegener's granulomatosis</strong>. The primary renal involvement is characterized by <strong>crescentic glomerulonephritis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>Wegener’s granulomatosis </strong>kidney shows<strong> crescentic glomerulonephritis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/909)</strong></i></span></p>",
      "correct_choice_id": 59762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14951,
      "choices": [
        {
          "id": 59764,
          "text": "<p><span style=\"font-size:12pt;\">Goodpasture syndrome</span></p>"
        },
        {
          "id": 59765,
          "text": "<p><span style=\"font-size:12pt;\">Churg-Strauss syndrome</span></p>"
        },
        {
          "id": 59766,
          "text": "<p><span style=\"font-size:12pt;\">Alport syndrome</span></p>"
        },
        {
          "id": 59767,
          "text": "<p><span style=\"font-size:12pt;\">Wegner’s granulomatosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The electron microscopy is virtually diagnostic in renal biopsy study of:</span></p>",
      "unique_key": "Q7096963",
      "question_audio": null,
      "question_video": null,
      "map_id": 32114,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Alport syndrome</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport syndrome </strong>shows a characteristic <strong>electron </strong>microscopy finding of the <strong>glomerular basement membrane (GBM), </strong>which is described as<strong> basket-weaving</strong>, due to <strong>splitting and lamellation of the lamina densa</strong>. This is a pathognomonic feature.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture5_o1fYjWl.jpg\" alt=\"\" width=\"1000\" height=\"348\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Goodpasture syndrome </strong>is characterized by the presence of <strong>anti-GBM antibodies </strong>leading to <strong>glomerulonephritis and pulmonary hemorrhage</strong>. <strong>Electron microscopy </strong>may show<strong> non-specific findings </strong>of glomerular damage rather than the <strong>specific changes seen in Alport syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Churg-Strauss syndrome, </strong>also known as<strong> eosinophilic granulomatosis with polyangiitis</strong>, is a form of <strong>vasculitis.</strong> <strong>Renal involvement can occur</strong>, but electron microscopy findings are <strong>not diagnostic </strong>of the condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Wegener’s granulomatosis, now known as granulomatosis with polyangiitis</strong>, may show evidence of<strong> small vessel vasculitis on biopsy</strong>, but electron microscopy is<strong> not typically diagnostic </strong>for this condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport syndrome's </strong>definitive <strong>morphological lesions </strong>are observable only by <strong>electron microscopy</strong>, which reveals a <strong>distinctive appearance of the GBM.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 922)</strong></i></span></p>",
      "correct_choice_id": 59766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14954,
      "choices": [
        {
          "id": 59776,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangioproliferative glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59777,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal and segmental glomerulosclerosis </span></span></span></p>"
        },
        {
          "id": 59778,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kimmelstiel-Wilson lesions </span></span></span></p>"
        },
        {
          "id": 59779,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyloidosis </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangial deposits of monoclonal kappa/lambda light chains in indicative of?</span></span></span></p>",
      "unique_key": "Q3903273",
      "question_audio": null,
      "question_video": null,
      "map_id": 32117,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Amyloidosis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amyloidosis </strong>is the <strong>correct</strong> answer, as it is specifically associated with the deposition of <strong>abnormal proteins</strong>, including <strong>AL proteins made of immunoglobulin light chains</strong>, within the<strong> kidney and other organs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangial deposits of <strong>monoclonal kappa/lambda </strong>light chains suggest the diagnosis of <strong>Amyloidosis. </strong>In primary Amyloidosis <strong>AL protein </strong>is deposited in the <strong>organs, </strong>which is made of<strong> light chains (usually lambda type) of immunoglobulins</strong>. <strong>Renal amyloi&shy;dosis </strong>is the <strong>most common cause of death due to amyloidosis </strong>(including both primary and second&shy;ary amyloidosis).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Mesangioproliferative glomerulonephritis </strong>involves <strong>proliferation </strong>of <strong>mesangial cells </strong>within the<strong> kidney </strong>but is not specifically associated with the deposition of light chains.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Focal and segmental glomerulosclerosis (FSGS) </strong>is characterized by <strong>segments of scarring in some glomeruli </strong>but <strong>does not </strong>feature <strong>light chain deposits</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Kimmelstiel-Wilson lesions </strong>are specific to <strong>diabetic nephropathy </strong>and exhibit <strong>nodular glomerulosclerosis, </strong>which also <strong>does not </strong>involve <strong>monoclonal light chains</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal amyloidosis </strong>can present with <strong>mesangial deposits </strong>of<strong> monoclonal kappa or lambda light chains </strong>and is associated with <strong>primary amyloidosis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 934)</span></span></em></strong></span></span></span></p>",
      "correct_choice_id": 59779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14966,
      "choices": [
        {
          "id": 59824,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Of its high concentration in plasma </span></span></span></p>"
        },
        {
          "id": 59825,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Has molecular weight slightly greater than the mol&shy;ecules normally getting filtered </span></span></span></p>"
        },
        {
          "id": 59826,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">High Albumin Globulin ratio </span></span></span></p>"
        },
        {
          "id": 59827,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubular epithelial cells are sensitive to albumin </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In renal disease, albumin is first to appear in urine because?</span></span></span></p>",
      "unique_key": "Q2725440",
      "question_audio": null,
      "question_video": null,
      "map_id": 32118,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Has molecular weight slightly greater than the molecules normally getting filtered </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The molecular weight of<strong> albumin is slightly greater </strong>than that of <strong>molecules normally filtered</strong>; however, <strong>albumin is still small </strong>enough (around<strong> 7nm </strong>in diameter) to be filtered if the<strong> charge barrier is compromised.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>filtration </strong>of any substance through<strong> glomerular filtration </strong>layer depends on <strong>two </strong>factors as described below: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture6_MHyFwW6.jpg\" style=\"height:323px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In some renal diseases, the <strong>anionic charge of the fil&shy;tration membrane is lost </strong>and this allows negatively charged particles of diameter <strong>8 nm </strong>to pass through it resulting in proteinuria. Albumin has a diameter of <strong>7 nm </strong>and it <em>starts appearing in urine as soon as the negative charge of filtration layer disappears. </em></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> High concentration </strong>in plasma <strong>does not </strong>inherently cause <strong>albumin to be filtered into the urine</strong>; it is the <strong>selectivity of the glomerular filter </strong>that is important.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> albumin-globulin ratio </strong>in the blood <strong>does not </strong>affect the <strong>selectivity of the glomerular filtration barrier directly</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Tubular reabsorption and sensitivity to albumin </strong>do not primarily determine its filtration, although <strong>damage to tubular cells </strong>can contribute to<strong> proteinuria </strong>if they are <strong>unable to reabsorb filtered proteins.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The main reason<strong> albumin </strong>is the <strong>first </strong>to appear in <strong>urine </strong>during renal disease is due to<strong> its size and charge</strong>. Normally, <strong>albumin is repelled </strong>by the <strong>negatively charged glomerular basement membrane</strong>, but when the <strong>charge barrier is lost due to renal disease, albumin can pass </strong>through <strong>more easily</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 911)</span></span></em></strong></p>",
      "correct_choice_id": 59825,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14968,
      "choices": [
        {
          "id": 59832,
          "text": "<p><span style=\"font-size:12pt;\">Fusion of foot processes of the glomerular epithelial cells</span></p>"
        },
        {
          "id": 59833,
          "text": "<p><span style=\"font-size:12pt;\">Rarefaction of glomerular basement membrane</span></p>"
        },
        {
          "id": 59834,
          "text": "<p><span style=\"font-size:12pt;\">Deposition of electron dense material in the basement membrane</span></p>"
        },
        {
          "id": 59835,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Thin basement membrane</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 7 year old boy presented with generalized edema. Urine examination revealed marked albuminuria. Serum biochemical examinations showed hypoalbuminemia with hyperlipidemia. Kidney biopsy was undertaken. On light microscopic examination, the kidney appeared normal. Electron microscopic examination is most likely to reveal:</span></p>",
      "unique_key": "Q4088833",
      "question_audio": null,
      "question_video": null,
      "map_id": 32119,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Fusion of foot process of the glomerular epi­thelial cells</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Fusion of foot processes </strong>of the <strong>glomerular epithelial cells </strong>is characteristic of <strong>minimal change disease</strong>. <strong>Electron microscopy </strong>will reveal<strong> effacement or fusion of the podocyte foot processes </strong>without<strong> immune complex deposition or complement activation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> child is presenting </strong>with features likely of <strong>Nephrotic syndrome </strong>whose most frequent cause in <strong>children is minimal change disease </strong>or<strong> lipoid nephrosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Light microscopy </strong>there is <strong>no abnormality </strong>whereas on <strong>electron microscopy </strong>there is <strong>fusion of foot pro­cesses of the glomerular epithelial cells </strong>with normal glomeruli.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Rarefaction of the glomerular basement membrane </strong>is <strong>not </strong>a feature of <strong>MCD </strong>but may be seen in other kidney diseases, such as Alport syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Deposition of electron-dense material in the basement membrane </strong>is typically observed in diseases such as <strong>membranous nephropathy</strong>, not MCD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> A <strong>thin basement membrane </strong>is characteristic of <strong>thin basement membrane disease</strong>, a condition separate from MCD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The primary finding in <strong>minimal change disease on electron microscopy </strong>is the<strong> effacement or fusion of podocyte foot processes, </strong>which helps in<strong> distinguishing it </strong>from <strong>other glomerular diseases </strong>that may present with<strong> normal findings on light microscopy </strong>but show <strong>specific abnormalities on electron microscopy.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 914)</strong></i></span></p>",
      "correct_choice_id": 59832,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14969,
      "choices": [
        {
          "id": 59836,
          "text": "<p><span style=\"font-size:12pt;\">Number of crescents</span></p>"
        },
        {
          "id": 59837,
          "text": "<p><span style=\"font-size:12pt;\">Size of crescents</span></p>"
        },
        {
          "id": 59838,
          "text": "<p><span style=\"font-size:12pt;\">Shape of crescents</span></p>"
        },
        {
          "id": 59839,
          "text": "<p><span style=\"font-size:12pt;\">Cellularity of crescents</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The prognosis of rapidly proliferating glomerulonephritis depends upon which of the following?</span></p>",
      "unique_key": "Q8026495",
      "question_audio": null,
      "question_video": null,
      "map_id": 32120,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Number of crescents</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>The Number of Crescents</strong>: This is the most important <strong>prognostic factor </strong>in <strong>rapidly proliferating glomerulonephritis. </strong>The <strong>more glomeruli </strong>that contain <strong>crescents, </strong>especially when <strong>more than 50% </strong>of the <strong>glomeruli </strong>are involved, the <strong>worse the prognosis </strong>is likely to be due to the associated <strong>reduction in functional renal tissue</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Crescents </strong>are formed by the <strong>proliferation of cells in Bowman's space </strong>(glomerular parietal epithelial cells, infiltrating monocytes/macrophages, and other cells). The presence of<strong> crescents </strong>indicates <strong>severe glomerular injury and inflammation</strong>, and the <strong>degree of crescent formation </strong>correlates with the <strong>extent of damage</strong>. The<strong> more crescents present</strong>, the greater the <strong>loss of functional glomerular tissue</strong>, leading to<strong> impaired kidney function </strong>and<strong> poorer prognosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Size of Crescents:</strong> While the<strong> size of crescents </strong>might reflect the<strong> severity of the initial injury</strong>, it is <strong>not </strong>as directly correlated with the<strong> prognosis </strong>as the <strong>number of affected glomeruli.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Shape of Crescents:</strong> The <strong>shape does not </strong>typically provide<strong> prognostic information</strong>. Crescents, by definition, are <strong>semi-lunar and their presence</strong>, regardless of shape, suggests <strong>significant pathology.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Cellularity of Crescents</strong>: Cellularity can give clues about the <strong>activity of the disease process </strong>(more cellular crescents may indicate more active disease), but again, the<strong> number of crescents is a stronger prognostic indicator</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In<strong> rapidly proliferating glomerulonephritis, </strong>the prognosis is primarily dependent on the<strong> number of crescents within the glomeruli</strong>, as this reflects the <strong>degree of glomerular damage and potential loss of kidney function</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 909)</strong></i></span></p>",
      "correct_choice_id": 59836,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14982,
      "choices": [
        {
          "id": 59888,
          "text": "<p><span style=\"font-size:12pt;\">Epithelial cells + fibrin + macrophage</span></p>"
        },
        {
          "id": 59889,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mesangial cell + fibrin + macrophage</span></p>"
        },
        {
          "id": 59890,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Tubular cell + mesangial cell + fibrin</span></p>"
        },
        {
          "id": 59891,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Neutrophil + tubular cell + fibrin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Crescents are derived from which of the following?</span></p>",
      "unique_key": "Q7502690",
      "question_audio": null,
      "question_video": null,
      "map_id": 32089,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Epithelial cells + fibrin + macrophage</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Epithelial cells + fibrin + macrophage Crescents </strong>are formed within <strong>Bowman's space </strong>during severe <strong>glomerular injury.</strong> <strong>Parietal</strong> <strong>epithelial cells line Bowman's capsule, </strong>and they proliferate in response to<strong> injury. Macrophages infiltrate</strong> the space as part of the inflammatory response, and <strong>fibrin is deposited </strong>due to the leakage of<strong> plasma proteins through the injured glomerular capillaries</strong>. This option <strong>correctly identifies </strong>the components of a <strong>crescent in proliferative forms of glomerulonephritis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The composition of crescents in glomerulonephritis:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Mesangial cell + fibrin + macrophage</strong>.&nbsp; While<strong> mesangial cells </strong>are indeed a<strong> component of the glomerulus </strong>and can <strong>proliferate in response to injury</strong>, they are <strong>not </strong>typically a part of the<strong> cellular makeup of crescents. Crescents are primarily </strong>composed of <strong>parietal epithelial cells</strong>, not mesangial cells.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Tubular cell + mesangial cell + fibrin Tubular cells </strong>are part of the <strong>nephron </strong>but <strong>not of the glomerulus</strong>, and they <strong>do not </strong>contribute to<strong> crescent formation</strong>. <strong>Mesangial cells</strong>, as mentioned earlier, <strong>reside within the glomerulus </strong>but <strong>do not form crescents.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Neutrophil + tubular cell + fibrin Neutrophils </strong>may be present in the<strong> glomerulus as part of an inflammatory response </strong>but are<strong> not </strong>a defining component of<strong> crescents</strong>. <strong>Tubular cells </strong>are<strong> not </strong>involved in <strong>crescent formation</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>Crescents </strong></i>are formed by proliferation of <strong>parietal cells </strong>and by <strong>migration of monocytes and macrophages </strong>into the urinary space. <strong>Neutrophils and lymphocytes </strong>may be present. <strong>Fibrin strands </strong>are frequently promi­nent <strong>between the cellular layers in the crescents. </strong>The escape of<strong> fibrinogen </strong>into Bowman space and its <strong>conver­sion to fibrin </strong>are an important contributor to<strong> crescent formation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 911)&nbsp;</strong></i></span></p>",
      "correct_choice_id": 59888,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14983,
      "choices": [
        {
          "id": 59892,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Malignant hypertension</span></p>"
        },
        {
          "id": 59893,
          "text": "<p><span style=\"font-size:12pt;\">Benign hypertension</span></p>"
        },
        {
          "id": 59894,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Chronic pyelonephritis</span></p>"
        },
        {
          "id": 59895,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Diabetes mellitus</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Flea bitten appearance of the kidney is seen in:</span></p>",
      "unique_key": "Q5302374",
      "question_audio": null,
      "question_video": null,
      "map_id": 32090,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Malignant hypertension</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture3.jpg\" alt=\"\" width=\"1000\" height=\"330\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Benign hypertension</strong>, also known as <strong>essential hypertension</strong>, is associated with<strong> long-standing high blood pressure</strong>. It can lead to <strong>hypertensive nephrosclerosis, </strong>characterized by <strong>arteriolar hyalinosis and ischemic </strong>changes in the <strong>kidney. </strong>However, \"flea-bitten\" appearance is not a specific term associated with this condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Chronic pyelonephritis </strong>is a condition characterized by<strong> chronic inflammation of the renal parenchyma</strong>, often <strong>secondary to recurrent urinary tract infections</strong>. It typically presents with <strong>scarring and atrophy of the renal papillae</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Long standing </strong>and <strong>uncontrolled diabetes </strong>can lead to <strong>diabetic nephropathy. </strong>This condition is characterized by<strong> glomerular basement membrane thickening and nodular glomerulosclerosis</strong> (Kimmelstiel-Wilson nodules).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mnemonic for differential diagnosis of flea bitten kid­ney: We HaTe PSM</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>W</strong>e -Wegener’s granulomatosis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>H</strong>a<strong>T</strong>e <strong>– H</strong>enoch Schonlein purpura; <strong>H</strong>US;<strong>T</strong>TP</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>P- P</strong>oststreptococcal glomerulonephritis (PSGN); <strong>P</strong>olyarteritis nodosa (PAN)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>S-S</strong>ubacute bacterial endocarditis (SABE)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>M- M</strong>alignant hypertension.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 939)</strong></i></span></p>",
      "correct_choice_id": 59892,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14989,
      "choices": [
        {
          "id": 59916,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heavy proteinuria, high cholesterol, high ASO titre </span></span></p>"
        },
        {
          "id": 59917,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heavy proteinuria, hematuria, low ASO titre </span></span></p>"
        },
        {
          "id": 59918,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild proteinuria, hematuria, high ASO titre </span></span></p>"
        },
        {
          "id": 59919,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild proteinuria, high cholesterol, normal ASO titre </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post streptococcal glomerulonephritis in children is diagnosed by: </span></span></p>",
      "unique_key": "Q7371402",
      "question_audio": null,
      "question_video": null,
      "map_id": 32092,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Mild proteinuria, hematuria, high ASO titre </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-streptococcal glomerulonephritis (PSGN) </strong>typically occurs after a<strong> streptococcal infection </strong>(such as <strong>strep throat or impetigo</strong>).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features of <strong>PSGN </strong>include <strong>mild proteinuria, hematuria, and elevated antistreptolysin O (ASO) titers.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Heavy proteinuria </strong>is<strong> more </strong>characteristic of <strong>nephrotic syndrome</strong>, which is not the typical presentation of PSGN.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Elevated cholesterol </strong>levels are<strong> more </strong>associated with<strong> nephrotic syndrome </strong>rather than PSGN.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features of<strong> </strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post streptococcal glomerulonephritis </strong>in <strong>children</strong></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> </strong>include <strong>mild proteinuria, hematuria, and elevated antistreptolysin O (ASO) titers</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 906) </span></span></em></strong></p>",
      "correct_choice_id": 59918,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14991,
      "choices": [
        {
          "id": 59924,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 59925,
          "text": "<p><span style=\"font-size:12.0pt;\">Hematuria</span></p>"
        },
        {
          "id": 59926,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephritic syndrome</span></p>"
        },
        {
          "id": 59927,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal biopsy having thin basement membrane</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">IgA nephropathy is characterized by all of the following except:</span></p>",
      "unique_key": "Q8779975",
      "question_audio": null,
      "question_video": null,
      "map_id": 32093,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Renal biopsy having thin basement membrane</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A<strong> thin basement membrane </strong>is <strong>not</strong> characteristic of <strong>IgA nephropathy;</strong> this finding is more commonly associated with<strong> thin basement membrane disease</strong>, which is a different condition.<strong> IgA nephropathy </strong>is characterized by<strong> mesangial cell proliferation and mesangial deposits of IgA immune complexes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>Hypertension </strong>can occur in<strong> IgA nephropathy </strong>due to ongoing<strong> kidney damage </strong>and is a common symptom associated with many <strong>chronic kidney diseases</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Hematuria, </strong>or blood in the urine, is a <strong>hallmark of IgA nephropathy. </strong>It can be recurrent and is often noticed following an <strong>upper respiratory tract infection</strong>, due to the<strong> mesangial deposition </strong>of<strong> IgA immune complexes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>IgA nephropathy </strong>can present with features of <strong>nephritic syndrome</strong>, which includes <strong>hematuria, </strong>variable degrees of <strong>proteinuria</strong>, and sometimes reduced <strong>kidney function</strong>. It<strong> does not </strong>typically present as <strong>full-blown nephrotic syndrome</strong>, which is characterized by<strong> severe proteinuria, hypoalbuminemia, edema, and hyperlipidemia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>IgA nephropathy, or Berger's disease</strong>, is identified by the presence of<strong> IgA deposits </strong>within the <strong>glomerular mesangium</strong>, which can lead to symptoms such as<strong> hematuria and hypertension. </strong>A <strong>thin basement membrane </strong>is<strong> not a feature </strong>of this condition and is typically observed in a separate condition known as<strong> thin basement membrane disease</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 922)</strong></i></span></p>",
      "correct_choice_id": 59927,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14992,
      "choices": [
        {
          "id": 59928,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100-150 mg/d </span></span></p>"
        },
        {
          "id": 59929,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">151-200 mg/d </span></span></p>"
        },
        {
          "id": 59930,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30-300 mg/d </span></span></p>"
        },
        {
          "id": 59931,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">301-600 mg/d </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microalbuminuria is defined as protein levels of:</span></span></span></p>",
      "unique_key": "Q5618699",
      "question_audio": null,
      "question_video": null,
      "map_id": 32094,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 30-300 mg/d</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microalbuminuria </strong>refers to the excretion of a<strong> moderately increased </strong>amount of <strong>albumin in the urine</strong>. The<strong> normal urinary albumin excretion </strong>rate is<strong> less than 30 mg/day.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microalbuminuria </strong>is often defined as a<strong> urinary albumin excretion rate of 30-300 mg/day. </strong>It is an <strong>early sign of kidney damage </strong>and is commonly associated with conditions such as<strong> diabetes and hypertension.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microalbuminuria </strong>is defined as protein levels of <strong>30-300 mg/day.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 923)</span></em></strong></span></span></p>",
      "correct_choice_id": 59930,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14993,
      "choices": [
        {
          "id": 59932,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SLE</span></span></p>"
        },
        {
          "id": 59933,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent hepatitis C infections </span></span></p>"
        },
        {
          "id": 59934,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial lipodystrophy </span></span></p>"
        },
        {
          "id": 59935,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neoplastic diseases </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I membranoproliferative glomerulonephritis is commonly associated with all except: </span></span></span></p>",
      "unique_key": "Q7697747",
      "question_audio": null,
      "question_video": null,
      "map_id": 32095,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Partial lipodystrophy </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial lipodystrophy&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is associated with <strong><em>C3 nephritic factor</em></strong><em> (C3NeF). </em>It is </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a<strong> rare disorder </strong>characterized by selective <strong>loss of adipose tissue</strong>. It has been reported as an association with<strong> Type II MPGN </strong>and <strong>not type I MPGN.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Type I membranoproliferative glomerulonephritis (MPGN) </strong>can be associated with<strong> SLE </strong>as it is associated with <strong>immune complex-mediated glomerulonephritis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Type I MPGN </strong>has a strong association with <strong>chronic infections</strong>, particularly persistent<strong> hepatitis C infections</strong>. The <strong>immune complexes </strong>formed during <strong>chronic infections </strong>can deposit in the<strong> glomeruli, leading to MPGN.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I MPGN </strong>has been associated with various <strong>neoplastic diseases</strong>, including <strong>hematological malignancies. </strong>The presence of malignancies can contribute to the formation of<strong> immune complexes</strong>, leading to <strong>glomerular deposition.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I MPGN </strong>is linked with conditions like <strong>systemic lupus erythematosus (SLE), </strong>chronic infections such as<strong> persistent hepatitis C</strong>, and certain<strong> neoplastic diseases </strong>due to the formation of<strong> immune complexes </strong>and their<strong> deposition in the kidneys</strong>. In contrast,<strong> partial lipodystrophy, </strong>a disorder characterized by the<strong> loss of adipose tissue</strong>, is commonly associated with <strong>Type II MPGN </strong>due to the presence of<strong> C3 nephritic factor (C3NeF), </strong>which <strong>stabilizes </strong>the <strong>alternative pathway C3 </strong>convertase leading to persistent activation of the<strong> complement system</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 918)</span></em></strong></span></span></p>",
      "correct_choice_id": 59934,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15000,
      "choices": [
        {
          "id": 59960,
          "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis</span></p>"
        },
        {
          "id": 59961,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Diabetes mellitus</span></p>"
        },
        {
          "id": 59962,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic kidney disease</span></p>"
        },
        {
          "id": 59963,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Benign nephrosclerosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In which of the following conditions bilateral contracted kidneys are characteristically seen?</span></p>",
      "unique_key": "Q8936249",
      "question_audio": null,
      "question_video": null,
      "map_id": 32097,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) Benign Nephrosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Benign nephrosclerosis</strong> is associated with <strong>long-standing hypertension </strong>and is characterized by <strong>symmetrically contracted kidneys</strong>. This is a result of <strong>chronic, benign vascular changes </strong>in the kidneys due to<strong> hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong> <strong>Amyloidosis </strong>is a condition characterized by the <strong>deposition of abnormal proteins (amyloid) </strong>in various organs, including the <strong>kidneys</strong>. It can lead to <strong>enlarged, pale kidneys </strong>rather than<strong> contracted ones</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Chronic diabetes </strong>can lead to <strong>diabetic nephropathy</strong>, which is associated with<strong> diffuse glomerulosclerosis</strong>. In the early stages,<strong> kidneys </strong>may be<strong> enlarged</strong>, but they typically <strong>do not show bilateral contraction.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C: Polycystic kidney disease:</strong> Characterised by enlarged kidney</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Direct quote from Robbins……</strong>‘In<strong> benign nephrosclerosis</strong>, kidneys are either <strong>normal or moderately reduced in size </strong>on gross appearance. The<strong> loss of mass </strong>is due mainly to<strong> cortical scarring and shrinking</strong>’.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 935)</strong></span></p>",
      "correct_choice_id": 59963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14970,
      "choices": [
        {
          "id": 59840,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post streptococcal glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59841,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangiocapillary glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59842,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryoglobulinemia </span></span></p>"
        },
        {
          "id": 59843,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SLE</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent low C3 complement level is not found in:</span></span></span></p>",
      "unique_key": "Q5441327",
      "question_audio": null,
      "question_video": null,
      "map_id": 32121,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Poststreptococcal glomerulonephritis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Poststreptococcal Glomerulonephritis -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although associated with <strong>transient hypocomplementemia</strong>, poststreptococcal glomerulonephritis <strong>does not </strong>typically present with <strong>persistent low levels of C3.</strong> C3 levels generally<strong> return to normal </strong>within several <strong>weeks after onset.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Mesangiocapillary Glomerulonephritis -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Persistent low C3 levels </strong>are commonly found in this condition due to continuous <strong>activation of the complement pathway</strong>, making it an important diagnostic marker.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Cryoglobulinemia -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition involves the formation of <strong>immune complexes </strong>that can<strong> consume complement proteins</strong>, leading to <strong>persistently low levels of C3.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: SLE -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Systemic lupus erythematosus, an <strong>autoimmune disease</strong>, often involves the formation of <strong>immune complexes </strong>and is typically associated with a<strong> persistent decrease </strong>in <strong>complement proteins</strong>, including<strong> C3</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Poststreptococcal glomerulonephritis </strong>typically exhibits a transient <strong>drop in C3 </strong>levels that resolves with the<strong> acute phase</strong>, while conditions like<strong> mesangiocapillary glomerulonephritis, cryoglobulinemia, and SLE </strong>can show <strong>sustained low </strong>levels indicative of ongoing <strong>immune complex activity and complement activation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 906)</span></span></em></strong></p>",
      "correct_choice_id": 59840,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14996,
      "choices": [
        {
          "id": 59944,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isomorphic RBCs</span></span></p>"
        },
        {
          "id": 59945,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBC casts </span></span></p>"
        },
        {
          "id": 59946,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephrotic range proteinuria </span></span></p>"
        },
        {
          "id": 59947,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eosinophiluria </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine analysis of a patient with haematuria and hypercalciuria is most likely to reveal which of the following?</span></span></span></p>",
      "unique_key": "Q4229922",
      "question_audio": null,
      "question_video": null,
      "map_id": 32096,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Isomorphic RBC </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Isomorphic RBCs </strong>in the <strong>urine </strong>refer to the presence of intact <strong>red blood cells </strong>without any significant changes in <strong>shape or size</strong>. The presence of <strong>isomorphic RBCs </strong>in urine suggests <strong>bleeding from a non glomerular </strong>cause in the<strong> kidney or the lower urinary tract</strong>, such as the<strong> bladder or urethra</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence o<strong>f RBC casts in urine </strong>indicates <strong>glomerular bleeding. </strong>Glomerular bleeding can occur in conditions such as <strong>glomerulonephritis or vasculitis</strong>. The formation of<strong> casts occurs within the renal tubules </strong>and is a characteristic finding in <strong>glomerular diseases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nephrotic range proteinuria </strong>refers to the<strong> excessive </strong>loss of <strong>protein in the urine</strong>, typically exceeding<strong> 3.5 grams per day</strong>. This condition is often associated with <strong>glomerular diseases</strong>, such as<strong> membranous nephropathy or minimal change disease. </strong>It may present with features like <strong>edema, hypoalbuminemia, and hyperlipidemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Eosinophiluria </strong>refers to the <strong>presence of eosinophils </strong>in the urine. It can be associated with <strong>allergic reactions, interstitial nephritis, or certain parasitic infections. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To <strong>diagnose </strong>the cause of <strong>hematuria </strong>in patients presenting with <strong>haematuria and hypercalciuria</strong>, it is crucial to examine the <strong>morphology of red blood cells (RBCs) </strong>in the urine.The presence of<strong> isomorphic RBCs </strong>implies <strong>bleeding </strong>from areas like the<strong> renal calyces, pelvis, ureter, bladder, or urethra</strong>, where the <strong>RBCs do not </strong>undergo significant <strong>alterations in shape. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Paediatric Nephrology 5<sup>th</sup> /141, 190 by Dr R.N. Srivas&shy;tava and Dr Arvind Bagga)</span></span></em></strong></p>",
      "correct_choice_id": 59944,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14952,
      "choices": [
        {
          "id": 59768,
          "text": "<p><span style=\"font-size:12pt;\">Tip variant</span></p>"
        },
        {
          "id": 59769,
          "text": "<p><span style=\"font-size:12.0pt;\">Collapsing</span></p>"
        },
        {
          "id": 59770,
          "text": "<p><span style=\"font-size:12.0pt;\">NOS</span></p>"
        },
        {
          "id": 59771,
          "text": "<p><span style=\"font-size:12.0pt;\">Perihilar</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 35-year-old man with a history of intravenous drug abuse presents with worsening kidney function. Renal biopsy reveals collapsing variant of focal segmental glomerulosclerosis (FSGS). Which of the following features is characteristic of this variant and is associated with a worse prognosis?</span></p>",
      "unique_key": "Q9552649",
      "question_audio": null,
      "question_video": null,
      "map_id": 32115,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Collapsing</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>collapsing variant </strong>is characterized by the<strong> collapse of glomerular capillaries </strong>and <strong>overt tuft collapse</strong>, which leads to <strong>rapid progression of renal disease </strong>and a<strong> poorer prognosis, </strong>making this the correct answer.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Five mutually exclusive variants of<strong> focal seg­mental glomerulosclerosis (FSGS) </strong>may be <strong>dis­tinguished </strong>by the<strong> pathological findings </strong>seen on<strong> renal biopsy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Collapsing variant</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Glomerular tip lesion variant</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cellular variant</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Perihilar variant</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Not otherwise specified variant (NOS)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;</strong>The tip variant of <strong>FSGS </strong>affects the segment of the glomerulus <strong>near the proximal tubule </strong>and is associated with <strong>better outcomes compared </strong>to <strong>other variants</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>NOS (not otherwise specified) </strong>variant is the<strong> most common type of FSGS </strong>and has a <strong>variable prognosis </strong>that is generally <strong>not as poor as </strong>the <strong>collapsing variant</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> The <strong>perihilar variant </strong>of <strong>FSGS </strong>has<strong> sclerotic lesions </strong>predominantly at the <strong>vascular pole of the glomerulus </strong>and <strong>does not </strong>typically <strong>progress as rapidly as </strong>the<strong> collapsing variant</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>NOS variant is the most common </strong>subtype and <strong>collapsing FSGS has worst prognosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbin’s 10<sup>th</sup>/ 916)</strong></span></p>",
      "correct_choice_id": 59769,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14949,
      "choices": [
        {
          "id": 59756,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal change disease </span></span></span></p>"
        },
        {
          "id": 59757,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rapidly progressive glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal and segmental glomerulosclerosis </span></span></span></p>"
        },
        {
          "id": 59759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rapidly non progressive glomerulonephritis </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crescent formation is characteristic of which of the following glomerular disease?</span></span></span></p>",
      "unique_key": "Q2134264",
      "question_audio": null,
      "question_video": null,
      "map_id": 32112,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Rapidly progressive glomerulonephritis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rapidly progressive glomerulonephritis </strong>is indeed associated with <strong>crescent formation</strong>, which can be seen in most of the<strong> glomeruli</strong>. This type of<strong> glomerulonephritis </strong>progresses <strong>quickly</strong>, often leading to<strong> renal failure </strong>in a <strong>short period of time.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rapidly progressive glomerulonephritis</strong>, also known as<strong> crescentic glomerulonephritis </strong>is charac&shy;terized by the <strong>presence of crescents </strong>in most of the glomeruli. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Crescents </strong>are produced by proliferation of the <strong><em>pari&shy;etal epithelial cells of Bowman&rsquo;s capsule and by infiltration of monocytes and macrophages</em></strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Minimal change disease </strong>typically presents with <strong>nephrotic syndrome </strong>and is characterized by <strong>minimal changes </strong>on <strong>light microscopy</strong>; specifically, it<strong> lacks inflammatory changes or crescents.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Focal and segmental glomerulosclerosis </strong>involves <strong>scarring in specific areas of the glomeruli</strong>. It is not primarily associated with crescent formation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The term <strong>&#39;rapidly non-progressive glomerulonephritis&#39; </strong>is not commonly used. However, any <strong>non-progressive form of glomerulonephritis </strong>would<strong> not </strong>typically feature<strong> crescent formation</strong>, which is indicative of a <strong>more aggressive disease process</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rapidly progressive glomerulonephritis </strong>is characterized by the <strong>formation of crescents</strong>, which are structures formed by the <strong>proliferation of parietal epithelial cells of Bowman&rsquo;s capsule </strong>and <strong>infiltration of monocytes and macrophages</strong>. This condition requires prompt <strong>diagnosis and treatment </strong>due to its <strong>rapid progression </strong>and potential to quickly lead to<strong> irreversible renal damage</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 909)</span></span></em></strong></p>",
      "correct_choice_id": 59757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14953,
      "choices": [
        {
          "id": 59772,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuft necrosis </span></span></span></p>"
        },
        {
          "id": 59773,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangiolysis </span></span></p>"
        },
        {
          "id": 59774,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parietal epithelial proliferation </span></span></span></p>"
        },
        {
          "id": 59775,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophy and necrosis of visceral epithelium </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a feature of collapsing glomerulopathy?</span></span></span></p>",
      "unique_key": "Q3124170",
      "question_audio": null,
      "question_video": null,
      "map_id": 32116,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Hypertrophy and necrosis of visceral epithe&shy;lium</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Collapsing glomerulopathy </strong>is a <strong>distinct </strong>pattern of <strong>glomerular injury </strong>characterized by <strong>hypertrophy and necrosis of visceral epithelial cells (podocytes). </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tuft necrosis </strong>refers to the <strong>destruction of the glomerular tuft</strong>, and this is <strong>not </strong>a characteristic feature of <strong>collapsing glomerulopathy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mesangiolysis </strong>involves <strong>disruption of mesangial cells and matrix</strong>, but it is <strong>not </strong>a prominent feature of <strong>collapsing glomerulopathy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Parietal epithelial proliferation </strong>is<strong> not </strong>a typical finding in <strong>collapsing glomerulopathy</strong>; instead, the <strong>pathology </strong>primarily involves changes in the<strong> visceral epithelial cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypertrophy and necrosis of visceral epithelium </strong>is a distinctive feature of <strong>collapsing glomerulopathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref. Robbin&rsquo;s 10<sup>th</sup>/ 917)</span></span></em></strong></p>",
      "correct_choice_id": 59775,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14985,
      "choices": [
        {
          "id": 59900,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berger disease </span></span></span></p>"
        },
        {
          "id": 59901,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal segmental glomerulosclerosis </span></span></span></p>"
        },
        {
          "id": 59902,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous glomerulonephritis </span></span></span></p>"
        },
        {
          "id": 59903,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal change disease </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common cause of nephritic syndrome in adults is: </span></span></span></p>",
      "unique_key": "Q4673805",
      "question_audio": null,
      "question_video": null,
      "map_id": 32091,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Berger disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgA nephropathy</strong>, also known as <strong>Berger&#39;s disease</strong>, is a common cause of <strong>nephritic syndrome </strong>in adults. It is characterized by the deposition of<strong> IgA immune complexes </strong>in the<strong> glomeruli, </strong>leading to <strong>inflammation and damage</strong>. This condition often presents with <strong>recurrent episodes of gross hematuria</strong>, usually following <strong>upper respiratory tract infections</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Focal segmental glomerulosclerosis </strong>is<strong> more commonly </strong>associated with <strong>nephrotic syndrome </strong>than nephritic syndrome. It involves <strong>scarring of some glomeruli</strong>, leading to<strong> proteinuria</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Membranous glomerulonephritis </strong>is also more commonly associated with<strong> nephrotic syndrome</strong>. It involves <strong>thickening </strong>of the<strong> glomerular basement membrane </strong>and can present with<strong> proteinuria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Minimal change disease </strong>is a common cause of <strong>nephrotic syndrome in children</strong>. It is characterized by <strong>minimal changes on light microscopy </strong>but significant <strong>proteinuria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Most </strong>common cause of<strong> nephritic syndrome in adults is Berger&rsquo;s disease</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 920) </span></span></em></strong></p>",
      "correct_choice_id": 59900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}